Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Prostate Cancer

  Free Subscription


01.08.2022

1 AJR Am J Roentgenol
1 BJU Int
1 Br J Cancer
1 Br J Radiol
1 Cancer Imaging
1 Eur Urol
1 Int J Cancer
3 Int J Radiat Oncol Biol Phys
1 Int J Urol
1 J Natl Cancer Inst
1 J Urol
1 Mod Pathol
1 Nat Rev Urol
1 PLoS One
3 Prostate
2 Radiology
1 Ther Adv Urol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol

  1. TURKBEY B, Haider MA
    Artificial Intelligence (AI) for Automated Cancer Detection on Prostate MRI: Opportunities and Ongoing Challenges, From the AJR Special Series on AI Applications.
    AJR Am J Roentgenol. 2021 Dec 8. doi: 10.2214/AJR.21.26917.
    PubMed         Abstract available


    BJU Int

  2. WILLIAMS IS, Perera S, Murphy DG, Corcoran NM, et al
    Active surveillance versus enzalutamide for low-risk prostate cancer- was it really a trial we needed?
    BJU Int. 2022 Jul 25. doi: 10.1111/bju.15860.
    PubMed        


    Br J Cancer

  3. SACHDEVA A, Hart CA, Kim K, Tawadros T, et al
    Non-canonical EphA2 activation underpins PTEN-mediated metastatic migration and poor clinical outcome in prostate cancer.
    Br J Cancer. 2022 Jul 22. pii: 10.1038/s41416-022-01914.
    PubMed         Abstract available


    Br J Radiol

  4. LIU Y, Wang S, Xiang LH, Xu G, et al
    The potential of a nomogram combined PI-RADS v2.1 and contrast-enhanced ultrasound (CEUS) to reduce unnecessary biopsies in prostate cancer diagnostics.
    Br J Radiol. 2022 Jul 25:20220209. doi: 10.1259/bjr.20220209.
    PubMed         Abstract available


    Cancer Imaging

  5. ZHANG YN, Lu ZG, Wang SD, Lu X, et al
    Gross tumor volume delineation in primary prostate cancer on (18)F-PSMA-1007 PET/MRI and (68)Ga-PSMA-11 PET/MRI.
    Cancer Imaging. 2022;22:36.
    PubMed         Abstract available


    Eur Urol

  6. GANDAGLIA G, Mazzone E, Stabile A, Pellegrino A, et al
    Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a
    Eur Urol. 2022 Jul 22. pii: S0302-2838(22)02417.
    PubMed         Abstract available


    Int J Cancer

  7. CARM KT, Johannessen B, Bogaard M, Bakken AC, et al
    Somatic mutations reveal complex metastatic seeding from multifocal primary prostate cancer.
    Int J Cancer. 2022 Jul 26. doi: 10.1002/ijc.34226.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  8. CHINNIAH S, Stish B, Costello BA, Pagliaro L, et al
    Radiotherapy in Oligometastatic Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2022 Jul 22. pii: S0360-3016(22)00732.
    PubMed         Abstract available

  9. HAMMER L, Jiang R, Hearn J, Lashbrook J, et al
    A Phase I Trial of Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for Locally Advanced Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2022 Jul 22. pii: S0360-3016(22)00736.
    PubMed         Abstract available

  10. CHOPADE P, Maitre P, David S, Panigrahi G, et al
    Common iliac node positive prostate cancer treated with curative radiotherapy: N1 or M1a?
    Int J Radiat Oncol Biol Phys. 2022 Jul 20. pii: S0360-3016(22)00731.
    PubMed         Abstract available


    Int J Urol

  11. KIMURA K, Kitajima K, Kawanaka Y, Yokoyama H, et al
    Evaluation of (11) C-choline positron emission tomography/computed tomography for determining treatment response in castration-resistant prostate cancer patients.
    Int J Urol. 2022 Jul 25. doi: 10.1111/iju.14992.
    PubMed         Abstract available


    J Natl Cancer Inst

  12. TAKAHASHI T
    RE: Grade Migration of Prostate Cancer in the United States during the last decade.
    J Natl Cancer Inst. 2022 Jul 26. pii: 6650145. doi: 10.1093.
    PubMed        


    J Urol

  13. BRANT A, Lewicki P, Wu X, Sze C, et al
    Impact of Left-digit Age Bias in the Treatment of Localized Prostate Cancer.
    J Urol. 2022 Jul 28:101097JU0000000000002857. doi: 10.1097/JU.0000000000002857.
    PubMed         Abstract available


    Mod Pathol

  14. CHAN E, McKenney JK, Hawley S, Corrigan D, et al
    Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for "large" cribriform prostatic adenocarcinoma.
    Mod Pathol. 2022;35:1092-1100.
    PubMed         Abstract available


    Nat Rev Urol

  15. LIGHT A, Ahmed HU, Shah TT
    The unclear role of PET-CT in localized radiorecurrent prostate cancer.
    Nat Rev Urol. 2022 Jul 25. pii: 10.1038/s41585-022-00635.
    PubMed        


    PLoS One

  16. OWOO B, Ninnoni JPK, Ampofo EA, Seidu AA, et al
    "I always find myself very tired and exhausted": The physical impact of caring; a descriptive phenomenological study of the experiences of prostate cancer caregivers in Cape Coast, Ghana.
    PLoS One. 2022;17:e0268627.
    PubMed         Abstract available


    Prostate

  17. ASKER H, Yilmaz-Oral D, Oztekin CV, Gur S, et al
    An update on the current status and future prospects of erectile dysfunction following radical prostatectomy.
    Prostate. 2022 May 17. doi: 10.1002/pros.24366.
    PubMed         Abstract available

  18. KHAN S, Vohra S, Farnan L, Elmore SNC, et al
    Using health insurance claims data to assess long-term disease progression in a prostate cancer cohort.
    Prostate. 2022 Jul 26. doi: 10.1002/pros.24418.
    PubMed         Abstract available

  19. YAZGAN SC, Yekeduz E, Utkan G, Urun Y, et al
    Prognostic role of pan-immune-inflammation value in patients with metastatic castration-resistant prostate cancer treated with androgen receptor-signaling inhibitors.
    Prostate. 2022 Jul 28. doi: 10.1002/pros.24419.
    PubMed         Abstract available


    Radiology

  20. LEE GH, Chatterjee A, Karademir I, Engelmann R, et al
    Comparing Radiologist Performance in Diagnosing Clinically Significant Prostate Cancer with Multiparametric versus Hybrid Multidimensional MRI.
    Radiology. 2022 Jul 26:211895. doi: 10.1148/radiol.211895.
    PubMed         Abstract available

  21. PECORARO M, Turkbey BI, Purysko AS, Girometti R, et al
    Diagnostic Accuracy and Observer Agreement of the MRI Prostate Imaging for Recurrence Reporting Assessment Score.
    Radiology. 2022 May 10:212252. doi: 10.1148/radiol.212252.
    PubMed         Abstract available


    Ther Adv Urol

  22. ELLIS EE, Frye TP
    Role of multi-parametric magnetic resonance imaging fusion biopsy in active surveillance of prostate cancer: a systematic review.
    Ther Adv Urol. 2022;14:17562872221106883.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: